3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE, 95%, 250mg

N-BOC-L-GLUTAMIC ACID DIMETHYL ESTER, 97.0%, 5g

1-[(4-Bromophenyl)sulphanyl]-4-nitrobenzene, 97.0%, 25g

3-(3-Bromo-5-fluorophenyl)propanoic acid, 97%, 100mg

2,2,2-Trifluoroacetic acid compound with 2-(8-azabicyclo[3.2.1]Octan-3-yl)acetic acid (1:1), 98%, 10g

2-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride, 95.0%, 1g

3-Bromo-8-methylimidazo[1,2-a]pyridine, 95.0%, 100mg

1-(4-Bromophenyl)-3-phenyl-1H-pyrazol-5-ylamine, 95.0%, 100mg

2-[2-(4-methyl-2-nitrophenyl)hydrazin-1-ylidene]-3-oxo-N-phenylbutanamide, 98%, 1g

Copper AAS standard solution, ROTI®Star, 500 ml, HDPE

(R)-1-(Thiazol-2-yl)ethanol, 97%, 1g

Methyl 4-amino-5-thiazolecarboxylate, 95.0%, 25g

Tolytriazole (mixture of isomers), 98.0%, 25g